Vor Biopharma Inc at Chardan Genetic Medicines Conference Transcript
Dr. Nathan Jorgensen, CFO of Vor Bio. The format for this session is a fireside chat. And we might open to audience Q&A at the end if there's time.
Questions & Answers
Nathan, thank you so much for joining us today. Can you start off by giving us some high-level introductory comments on Vor for those that might be new to the story? And also highlight for us some recent milestones and upcoming catalysts. And then we'll dive into your pipeline and programs in more detail.
Thank you. And thank you for having us at the Chardan Conference. So Vor was founded to solve one of the big issues for a cancer drug development. And that's there aren't any really good targets.
And so our approach is, we take a bone marrow transplant for some of these cancers, such as AML, where it's a standard of care. And we delete up a protein. And so then, when that transplant
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
